Phoenix SARMS Pharm Owner Sentenced to Prison; Company Must Close and Forfeit $1.8 Million
Prosecutors say the business made at least $3.5 million selling unapproved steroid-like drugs shipped from China in mislabeled packages.
FDA
Read More
FDA Lists Recall of 4.3 Million Tubes of Kids’ and Other Fluoride Toothpaste
Brands include Crayola, Hot Wheels, My Little Pony and Brush Buddies; no illnesses have been reported.
FDA’s abortion pill safety review will stretch into 2027, agency tells court
The agency expects a mifepristone safety study by mid-December and a report ‘no later than March 2027.’
FDA Approves Tecelra Gene Therapy for Unresectable Synovial Sarcoma
The U.S. Food and Drug Administration (FDA) has granted approval for Tecelra (afamitresgene autoleucel), a groundbreaking gene therapy designed to treat adults with unresectable or metastatic synovial sarcoma. This approval represents a significant advancement in cancer treatment options for patients who have exhausted standard therapies. Synovial Sarcoma: A Rare Challenge Synovial sarcoma is a rare…
FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
The U.S. Food and Drug Administration (FDA) has approved Zurnai, a groundbreaking nalmefene hydrochloride auto-injector designed for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients aged 12 years and older. This approval follows the agency’s earlier authorization of the first nasal spray formulation of nalmefene in May 2023. Opioid…